[图书][B] Angiogenesis, cyclooxygenase-2 and matrix metalloproteinases in malignant mesothelioma

JG Edwards - 2002 - search.proquest.com
Malignant Mesothelioma (MM) is a fatal tumour, related to prior asbestos exposure, of
increasing incidence. Current treatment modalities may provide symptom palliation but …

Klinische Wirksamkeit der COX-2-Hemmer

K Krüger - Bundesgesundheitsblatt-Gesundheitsforschung …, 2002 - Springer
Nach Publikation von zahlreichen kontrollierten Studien und zweijähriger Erfahrung in der
praktischen Anwendung kann die klinische Wirksamkeit der beiden zugelassenen COX-2 …

Karzinomrisiko und Pravention bei chronisch entzundlichen Darmerkrankungen

H Herfarth - Chirurgische Gastroenterologie, 2002 - karger.com
Bei Patienten, die unter einer Colitis ulcerosa oder einem Morbus Crohn mit einer
vornehmlichen Lokalisation im Kolon leiden, ist das Risiko, ein kolorektales Karzinom zu …

Precancerous Lesions in the Large Intestine of Rodents

H Mori, Y Yamada - Journal of Toxicologic Pathology, 2002 - jstage.jst.go.jp
As precancerous lesions for large bowel cancers, early appearing lesions like aberrant crypt
foci (ACF) are recognized. Recently, we identified β-cetenin accumulated crypts (BCAC) in …

[PDF][PDF] WOMEN'S HEALTH STATUS REPORT

DE Stewart, AM Cheung, LE Ferris, I Hyman… - disabilitystudies.ca
Background Disability is a term with many different meanings. Some assume it refers simply
to a medical or psychological condition that limits functioning within society. According to the …

COLON CANCER AND EXPOSURE TO EXOGENOUS SEX STEROIDS

F Al-Azzawi - Hormone Replacement Therapy and Cancer: The …, 2002 - books.google.com
Cancer is thought to result from an accumulation of irreversible genetic defects. Two classes
of genes, proto-oncogenes and tumor suppressor genes, have been identified, mutations of …

[图书][B] Use of HMG CoA reductase inhibitors and the risk of colorectal cancer

KP Bjork - 2002 - search.proquest.com
Experimental studies suggest that the lipid lowering drugs known as HMG CoA reductase
inhibitors (HMGs) may have chemopreventive potential against colorectal cancer (CRC) …

大腸癌とCOX-2 消化癌のトピックス

太田慎一, 伴場裕巳, 今井幸紀, 新井晋… - 日本消化器病学会 …, 2002 - jstage.jst.go.jp
抄録 大腸癌の予防は重要な課題であり, この点でプロスタグランジン合成酵素である COX-2
が注目を集めている. 家族性大腸腺腫症ではヒトで有意の腺腫に対する退縮効果が報告された …

COX-2 阻害薬, 腸ポリープ症抑制, そして癌の化学予防

大島正伸, 武藤誠 - 日本薬理学雑誌, 2002 - jstage.jst.go.jp
抄録 化学発癌物質誘発ラットモデルを用いた実験により非ステロイド抗炎症薬 (NSAIDs)
が腸管の腫瘍細胞増殖を抑制することが示唆された. さらに大規模な疫学調査や …

[引用][C] The role of COX-2 inhibition in the treatment of colorectal cancer

DJ Richel - Simposio Internacional, 2002